These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30208864)

  • 1. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
    Stosic M; Vukovic D; Babic D; Antonijevic G; Foley KL; Vujcic I; Grujicic SS
    BMC Public Health; 2018 Sep; 18(1):1114. PubMed ID: 30208864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
    Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B
    Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.
    Desissa F; Workineh T; Beyene T
    BMC Public Health; 2018 Apr; 18(1):422. PubMed ID: 29606112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
    Elduma AH; Mansournia MA; Foroushani AR; Ali HMH; Elegail AMA; Elsony A; Holakouie-Naieni K
    Epidemiol Health; 2019; 41():e2019014. PubMed ID: 31010280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study.
    Admassu F; Abera E; Gizachew A; Sedoro T; Gari T
    BMJ Open; 2023 Jan; 13(1):e061836. PubMed ID: 36639214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh.
    Rifat M; Hall J; Oldmeadow C; Husain A; Hinderaker SG; Milton AH
    BMJ Open; 2015 Sep; 5(9):e008273. PubMed ID: 26351185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study.
    Iradukunda A; Ndayishimiye GP; Sinarinzi D; Odjidja EN; Ntakaburimvo N; Nshimirimana I; Izere C
    BMC Public Health; 2021 Nov; 21(1):2142. PubMed ID: 34814876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
    Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
    BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.
    Hirpa S; Medhin G; Girma B; Melese M; Mekonen A; Suarez P; Ameni G
    BMC Public Health; 2013 Aug; 13():782. PubMed ID: 23981845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system.
    Khan MS; Hutchison C; Coker RJ; Yoong J; Hane KM; Innes AL; Khaing TM; Aung S
    Health Policy Plan; 2017 Oct; 32(suppl_2):i43-i50. PubMed ID: 29028228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
    Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
    Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
    Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
    Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.
    Ambaye GY; Tsegaye GW
    Ethiop J Health Sci; 2021 Jan; 31(1):25-34. PubMed ID: 34158749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.